A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
Clinical trial NCT06755944 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06755944
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-15
- Primary completion
- 2025-06-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.